Abstract: The invention provides a human ena/VASP-like protein splice variant (EVL1) and polynucleotides which identify and encode EVL1. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of EVL 1.
Type:
Grant
Filed:
February 20, 1998
Date of Patent:
June 15, 1999
Assignee:
Incyte Pharmaceuticals, Inc.
Inventors:
Preeti Lal, Karl J. Guegler, Neil C. Corley